Shigellosis - Annual Epidemiological Report for 2016

Surveillance report
Publication series: Annual Epidemiological Report on Communicable Diseases in Europe
Time period covered: This report is based on data for 2016 retrieved from The European Surveillance System (TESSy) on 21 February 2018.

 European Centre for Disease Prevention and Control. Shigellosis. In: ECDC. Annual epidemiological report for 2016. Stockholm: ECDC; 2018. 

Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. In 2016, 29 EU/EEA countries reported 5 631 confirmed shigellosis cases.


More on this site

Factsheet about shigellosis

Shigellosis is caused by Shigella bacteria, which includes several species pathogenic to man, with humans as the main reservoir.

All annual Epidemiological Reports (AERs)

The Annual Epidemiological Reports (AERs) are key ECDC publication on the epidemiology of communicable diseases of public health significance in Europe. These reports give overviews of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union (EU) and European Economic Area (EEA) countries.

More about food- and waterborne diseases

Food-borne diseases

Climatic factors influence the growth and survival of pathogens, as well as transmission pathways. Higher ambient temperatures increase replication cycles of food-borne pathogens, and prolonged seasons may augment the opportunity for food handling mistakes - in 32% of investigated food-borne outbreaks in Europe “temperature misuse” is considered a contributing factor.

European Food- and Waterborne Diseases and Zoonoses Network (FWD-Net)

The FWD-Net network advises ECDC and contributes to strengthening surveillance and prevention of 21 food- and waterborne diseases and zoonoses in the EU/EEA, in close collaboration with EFSA, WHO and global public health partners. Activities include microbiology capacity building, EQA schemes and harmonization of laboratory-based surveillance.